New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 21, 2014
06:34 EDTVRX, AGNCapital Research sells nearly all its Allergan stake, WSJ reports
Capital Research, one of Allergan's (AGN) top shareholders, has sold most of its stake in the Botox maker after meeting with Allergan CEO David Pyott, the Wall Street Journal reports, citing sources. Allergan is looking to fend off a $53B hostile takeover offer by Valeant (VRX) and activist Bill Ackman. According to FactSet, Captial Research held a 6.3% stake in Allergan. Reference Link
News For AGN;VRX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 24, 2015
09:18 EDTVRXValeant and Progenics' Relistor eceives positive opinion from EMA
Valeant (VRX) and Progenics (PGNX) announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion recommending a new indication for Relistor Subcutaneous Injection for the treatment of opioid-induced constipation when response to laxative therapy has not been sufficient in adult patients, aged 18 years and older. Additionally, the Committee has recommended a one-year extension of data/marketing protection for Relistor, to 11 years from the date of approval.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use